CN Patent

CN114642633A — 一种氨己烯酸制剂液体组合物

Assigned to Shanghai Aucta Pharmaceuticals Co Ltd · Expires 2022-06-21 · 4y expired

What this patent protects

本发明公开了一种氨己烯酸制剂液体组合物，还公开了一种由所述组合物和稀释液制备而成的口服溶液，该溶液适用于CNS疾病的治疗，例如抗性癫痫，复杂部分性癫痫发作，继发性全身性癫痫发作，难治性复杂部分性发作和婴儿痉挛的患者。该可多次使用的剂型稳定性良好，为医护人员提供了便利，改善患者依从性并减少配药时的人为错误，这也提高了儿童和婴儿的用药安全性。

USPTO Abstract

本发明公开了一种氨己烯酸制剂液体组合物，还公开了一种由所述组合物和稀释液制备而成的口服溶液，该溶液适用于CNS疾病的治疗，例如抗性癫痫，复杂部分性癫痫发作，继发性全身性癫痫发作，难治性复杂部分性发作和婴儿痉挛的患者。该可多次使用的剂型稳定性良好，为医护人员提供了便利，改善患者依从性并减少配药时的人为错误，这也提高了儿童和婴儿的用药安全性。

Drugs covered by this patent

Patent Metadata

Patent number: CN114642633A
Jurisdiction: CN
Classification: —
Expires: 2022-06-21
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Aucta Pharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.